Decentralized trials

Castor announced continued support for the WHO Solidarity trial, the world’s largest adaptive COVID-19 trial.

Learn why myTomorrows utilizes Castor to monitor treatment and assess benefit/risk its users, connecting patients with expanded trial access.

Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing…

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…

The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here…

To support our growing customer base in the APAC region, we established new hosting in Australia. By allowing…